Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '6-BETA-HYDROXYCORTISOL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Eeckhoudt, SL; Desager, JP; Robert, AR; Leclercq, I; Verbeeck, RK; Horsman, Y
      Midazolam and cortisol metabolism before and after CYP3A induction in humans

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    2. Micuda, S; Hodac, M; Sispera, L; Parizek, P; Pleskot, M; Zimova, G; Cerman, J; Martinkova, J; Pidrman, V
      Influence of amiodarone on urinary excretion of 6 beta-hydroxycortisol in humans

      PHYSIOLOGICAL RESEARCH
    3. Boulton, DW; Arnaud, P; DeVane, CL
      A single dose of methadone inhibits cytochrome P-4503A activity in healthyvolunteers as assessed by the urinary cortisol ratio

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    4. Charlier, C; Dessalles, MC; Plomteux, G
      Methadone maintenance treatment: Is it possible to adapt the daily doses to the metabolic activity of the patient?

      THERAPEUTIC DRUG MONITORING
    5. Hsieh, KP; Lin, YY; Cheng, CL; Lai, ML; Lin, MS; Siest, JP; Huang, JD
      Novel mutations of CYP3A4 in Chinese

      DRUG METABOLISM AND DISPOSITION
    6. Yasui-Furukori, N; Kondo, T; Kubota, T; Otake, H; Ohkubo, T; Nagasaki, T; Sugawara, K; Chiba, K; Otani, K; Kaneko, S
      No correlations between the urinary ratio of 6 beta-hydroxycortisol to free cortisol and pharmacokinetics of alprazolam

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    7. Konishi, H; Takenaka, A; Minouchi, T; Yamaji, A
      Impairment of CYP3A4 capacity in patients receiving danazol therapy: Examination on oxidative cortisol metabolism

      HORMONE AND METABOLIC RESEARCH
    8. Ohno, M; Yamaguchi, I; Saiki, K; Yamamoto, I; Azuma, J
      Specific determination of urinary 6 beta-hydroxycortisol and cortisol by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    9. Tang, CY; Kassahun, K; McIntosh, IS; Brunner, J; Rodrigues, AD
      Simultaneous determination of urinary free cortisol and 6 beta-hydroxycortisol by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry and its application for estimating hepatic CYP3A induction

      JOURNAL OF CHROMATOGRAPHY B
    10. Furuta, T; Matsuzawa, M; Shibasaki, H; Kasuya, Y
      Simultaneous determination of 6 beta- and 6 alpha-hydroxycortisols and 6 beta-hydroxycortisone in human urine by stable isotope dilution mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    11. Verplanke, AJW; Bloemen, LJ; Brouwer, EJ; Van Sittert, NJ; Boogaard, PJ; Herber, RFM; De Wolff, FA
      Occupational exposure to cis-l,3-dichloropropene: biological effect monitoring of kidney and liver function

      OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    12. Yamamoto, N; Tamura, T; Kamiya, Y; Sekine, I; Kunitoh, H; Saijo, N
      Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol

      JOURNAL OF CLINICAL ONCOLOGY
    13. Homma, M; Beckerman, K; Hayashi, S; Jayewardene, AL; Oka, K; Gambertoglio, JG; Aweeka, FT
      Liquid chromatographic determination of urinary 6 beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    14. Pichard-Garcia, L; Hyland, R; Baulieu, J; Fabre, JM; Milton, A; Maurel, P
      Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo

      DRUG METABOLISM AND DISPOSITION
    15. Depre, M; Ehrich, E; Van Hecken, A; De Lepeleire, I; Dallob, A; Wong, P; Porras, A; Gertz, BJ; De Schepper, PJ
      Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    16. Ohno, M; Yamaguchi, I; Ito, T; Saiki, K; Yamamoto, I; Azuma, J
      Circadian variation of the urinary 6 beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    17. Wentworth, JM; Agostini, M; Love, J; Schwabe, JW; Chatterjee, VKK
      St John's wort, a herbal antidepressant, activates the steroid X receptor

      JOURNAL OF ENDOCRINOLOGY
    18. Roby, CA; Anderson, GD; Kantor, E; Dryer, DA; Burstein, AH
      St John's Wort: Effect on CYP3A4 activity

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    19. Fenske, M
      Determination of cortisol and cortisone in human morning and overnight urine by thin-layer chromatography and fluorescence derivatisation with isonicotinic acid hydrazide

      CHROMATOGRAPHIA
    20. Keung, A; Reith, K; Eller, MG; McKenzie, KA; Cheng, L; Weir, SJ
      Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: Part I

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    21. Galmier, MJ; Beyssac, E; Petit, J; Aiache, JM; Lartigue, C
      Validation of a reversed-phase liquid chromatographic method for the determination of hydrocortisone phosphate disodium in a gel formulation

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    22. Totsuka, S; Watanabe, T; Koyanagi, F; Tanaka, K; Yasuda, M; Manabe, S
      Increase in urinary excretion of 6 beta-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction

      ARCHIVES OF TOXICOLOGY
    23. Nakamura, H; Hasegawa, A; Kimura, M; Yamagata, S; Nakasa, H; Osada, H; Sekiya, S; Ohmori, S; Kitada, M
      Comparison of urinary 6 beta-hydroxycortisol/cortisol ratio between neonates and their mothers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    24. Pierce, CH; Houle, JM; Dickinson, JP; Kindermans, M; Serre-Lacroix, E; Kieffer, G; Necciari, J
      Clopidogrel and drug metabolism: Absence of effect on hepatic enzymes in healthy volunteers

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    25. Weber, C; Schmitt, R; Birnboeck, H; Hopfgartner, G; Eggers, H; Meyer, J; van Marle, S; Viischer, HW; Jonkman, JHG
      Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    26. Kostrubsky, VE; Ramachandran, V; Venkataramanan, R; Dorko, K; Esplen, JE; Zhang, SM; Sinclair, JF; Wrighton, SA; Strom, SC
      The use of human hepatocyte cultures to study the induction of cytochrome P-450

      DRUG METABOLISM AND DISPOSITION
    27. Starkel, P; Sempoux, C; Van den Berge, V; Stevens, M; De Saeger, C; Desager, JP; Horsmans, Y
      CYP 3A proteins are expressed in human neutrophils and lymphocytes but arenot induced by rifampicin

      LIFE SCIENCES
    28. SHIBATA N; HAYAKAWA T; TAKADA K; HOSHINO N; MINOUCHI T; YAMAJI A
      SIMULTANEOUS DETERMINATION OF GLUCOCORTICOIDS IN PLASMA OR URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH PRECOLUMN FLUOROMETRIC DERIVATIZATION BY 9-ANTHROYL NITRILE

      Journal of chromatography B. Biomedical sciences and applications
    29. TERRA SG; WASHAM JB; MAY DB
      COMMENT - TROGLITAZONE DRUG-INTERACTIONS

      The Annals of pharmacotherapy
    30. PAGEAUX GP; LEBRICQUIR Y; BERTHOU F; BRESSOT N; PICOT MC; BLANC F; MICHEL H; LARREY D
      EFFECTS OF INTERFERON-CV ON CYTOCHROME-P-450 ISOFORMS 1A2 AND 3A ACTIVITIES IN PATIENTS WITH CHRONIC HEPATITIS-C

      European journal of gastroenterology & hepatology
    31. SEIDMAN AD; HUDIS CA; ALBANEL J; TONG W; TEPLER I; CURRIE V; MOYNAHAN ME; THEODOULOU M; GOLLUB M; BASELGA J; NORTON L
      DOSE-DENSE THERAPY WITH WEEKLY 1-HOUR PACLITAXEL INFUSIONS IN THE TREATMENT OF METASTATIC BREAST-CANCER

      Journal of clinical oncology
    32. ANDERSON GD; AWAN AB; ADAMS CA; TEMKIN NR; WINN HR
      INCREASES IN METABOLISM OF VALPROATE AND EXCRETION OF 6-BETA-HYDROXYCORTISOL IN PATIENTS WITH TRAUMATIC BRAIN INJURY

      British journal of clinical pharmacology
    33. SEIDEGARD J; DAHLSTROM K; KULLBERG A
      EFFECT OF GRAPEFRUIT JUICE ON URINARY 6-BETA-HYDROXYCORTISOL CORTISOLEXCRETION/

      Clinical and experimental pharmacology and physiology
    34. GHARAIBEH MN; GILLEN LP; OSBORNE B; SCHWARTZ JI; WALDMAN SA
      EFFECT OF MULTIPLE DOSES OF RIFAMPIN ON THE [C-14 N-METHYL] ERYTHROMYCIN BREATH TEST IN HEALTHY MALE-VOLUNTEERS

      Journal of clinical pharmacology
    35. MONSARRAT B; CHATELUT E; ROYER I; ALVINERIE P; DUBOIS J; DEZEUSE A; ROCHE H; CROS S; WRIGHT M; CANAL P
      MODIFICATION OF PACLITAXEL METABOLISM IN A CANCER-PATIENT BY INDUCTION OF CYTOCHROME-P450 3A4

      Drug metabolism and disposition
    36. SVENSSON USH; ASHTON M; HAI TN; BERTILSSON L; HUONG DX; VANHUONG N; NIEU NT; SY ND; LYKKESFELDT J; CONG LD
      ARTEMISININ INDUCES OMEPRAZOLE METABOLISM IN HUMAN-BEINGS

      Clinical pharmacology and therapeutics
    37. VONBAHR C; STEINER E; KOIKE Y; GABRIELSSON J
      TIME-COURSE OF ENZYME-INDUCTION IN HUMANS - EFFECT OF PENTOBARBITAL ON NORTRIPTYLINE METABOLISM

      Clinical pharmacology and therapeutics
    38. LEE C; GOEGER DE
      INTERFERENCE OF 6-BETA-HYDROXYCORTISOL IN THE QUANTITATION OF URINARYFREE CORTISOL BY IMMUNOASSAY AND ITS ELIMINATION BY SOLID-PHASE EXTRACTION

      Clinical biochemistry
    39. YEUNG JHK; WONG JKL; PARK BK
      DEVELOPMENT OF A MONOCLONAL-ANTIBODY TO 6-BETA-HYDROXYCORTISOL AND ITS APPLICATION IN AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) FOR 6-BETA-HYDROXYCORTISOL IN URINE

      Journal of pharmacological and toxicological methods
    40. REICHEL C; BLOCK W; SKODRA T; TRABER F; SCHIEDERMAIER P; SPENGLER U; NUBER R; SCHILD HH; SAUERBRUCH T
      RELATIONSHIP BETWEEN CYTOCHROME-P-450 INDUCTION BY RIFAMPICIN, HEPATIC VOLUME AND PORTAL BLOOD-FLOW IN MAN

      European journal of gastroenterology & hepatology
    41. ROST KL; MANSMANN U; ROOTS I
      URINARY 6-BETA-HYDROXYCORTISOL AND D-GLUCARIC ACID EXCRETION RATES ARE NOT AFFECTED BY LANSOPRAZOLE TREATMENT

      International journal of clinical pharmacology and therapeutics
    42. YEUNG JHK; WONG JKL; PARK BK
      DEVELOPMENT OF A SCREENING METHOD FOR ANTI-6-BETA-HYDROXYCORTISOL ANTIBODY USING AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) AND ITS APPLICATIONS

      Methods and findings in experimental and clinical pharmacology
    43. BEYELER C; FREY BM; BIRD HA
      URINARY 6-BETA-HYDROXYCORTISOL EXCRETION IN RHEUMATOID-ARTHRITIS

      British journal of rheumatology
    44. WILLIAMS JA; CHENERY RJ; BERKHOUT TA; HAWKSWORTH GM
      INDUCTION OF CYTOCHROME P4503A BY THE ANTIGLUCOCORTICOID MIFEPRISTONEAND A NOVEL HYPOCHOLESTEROLEMIC DRUG

      Drug metabolism and disposition
    45. BOISSONNAT P; DELORGERIL M; PERROUX V; SALEN P; BATT AM; BARTHELEMY JC; BROUARD R; SERRES E; DELAYE J
      A DRUG-INTERACTION STUDY BETWEEN TICLOPIDINE AND CYCLOSPORINE IN HEART-TRANSPLANT RECIPIENTS

      European Journal of Clinical Pharmacology
    46. BARTOLI A; GATTI G; CIPOLLA G; BARZAGHI N; VELIZ G; FATTORE C; MUMFORD J; PERUCCA E
      A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON THE EFFECT OF VIGABATRIN ON IN-VIVO PARAMETERS OF HEPATIC-MICROSOMAL ENZYME-INDUCTION AND ON THE KINETICS OF STEROID ORAL-CONTRACEPTIVES IN HEALTHY FEMALE VOLUNTEERS

      Epilepsia
    47. TRAN A; REY E; PONS G; ROUSSEAU M; DATHIS P; OLIVE G; MATHER GG; BISHOP FE; WURDEN CJ; LABROO R; TRAGER WF; KUNZE KL; THUMMEL KE; VINCENT JC; GILLARDIN JM; LEPAGE F; LEVY RH
      INFLUENCE OF STIRIPENTOL ON CYTOCHROME P450-MEDIATED METABOLIC PATHWAYS IN HUMANS - IN-VITRO AND IN-VIVO COMPARISON AND CALCULATION OF IN-VIVO INHIBITION CONSTANTS

      Clinical pharmacology and therapeutics
    48. MADSEN H; RASMUSSEN BB; BROSEN K
      IMIPRAMINE DEMETHYLATION IN-VIVO - IMPACT OF CYP1A2, CYP2C19, AND CYP3A4

      Clinical pharmacology and therapeutics
    49. KOCAREK TA; REDDY AB
      REGULATION OF CYTOCHROME-P450 EXPRESSION BY INHIBITORS OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE IN PRIMARY CULTURED RAT HEPATOCYTES AND IN RAT-LIVER

      Drug metabolism and disposition
    50. PALERMO M; GOMEZSANCHEZ C; ROITMAN E; SHACKLETON CHL
      QUANTITATION OF CORTISOL AND RELATED 3-OXO-4-ENE STEROIDS IN URINE USING GAS-CHROMATOGRAPHY MASS-SPECTROMETRY WITH STABLE ISOTOPE-LABELED INTERNAL STANDARDS

      Steroids
    51. BROCKS DR; UPWARD JW; GEORGIOU P; STELMAN G; DOYLE E; ALLEN E; WYLD P; DENNIS MJ
      THE SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF PRANLUKAST IN HEALTHY-VOLUNTEERS

      European Journal of Clinical Pharmacology
    52. VAUZELLEKERVROEDAN F; REY E; PARIENTEKHAYAT A; BIENVENU T; BADOUAL J; OLIVE G; PONS G
      NON INVASIVE IN-VIVO STUDY OF THE MATURATION OF CYP IIIA IN NEONATES AND INFANTS

      European Journal of Clinical Pharmacology
    53. TOMLINSON B; YOUNG RP; NG MCY; ANDERSON PJ; KAY R; CRITCHLEY JAJH
      SELECTIVE LIVER-ENZYME INDUCTION BY CARBAMAZEPINE AND PHENYTOIN IN CHINESE EPILEPTICS

      European Journal of Clinical Pharmacology
    54. FLEISHAKER JC; PEARSON PG; WIENKERS LC; PEARSON LK; PETERS GR
      BIOTRANSFORMATION OF TIRILAZAD IN HUMAN .2. EFFECT OF KETOCONAZOLE ONTIRILAZAD CLEARANCE AND ORAL BIOAVAILABILITY

      The Journal of pharmacology and experimental therapeutics
    55. GOLDBERG MR; LO MW; DEUTSCH PJ; WILSON SE; MCWILLIAMS EJ; MCCREA JB
      PHENOBARBITAL MINIMALLY ALTERS PLASMA-CONCENTRATIONS OF LOSARTAN AND ITS ACTIVE METABOLITE E-3174

      Clinical pharmacology and therapeutics
    56. NG MCY; YOUNG RP; CRITCHLEY JAJH; LEUNG NWY; LAU JWY; LI AKC
      URINARY 6-BETA-HYDROXYCORTISOL EXCRETION IN HONG-KONG CHINESE PATIENTS WITH HEPATOCELLULAR-CARCINOMA AND OTHER CHRONIC LIVER-DISEASES

      Cancer
    57. HOSHINO U; KAWASAKI H
      URINARY 6-BETA-HYDROXYCORTISOL EXCRETION IN PATIENTS WITH ALCOHOLIC LIVER-DISEASE

      Research communications in alcohol and substances of abuse
    58. WANWIMOLRUK S; KANG W; COVILLE PF; VIRIYAYUDHAKORN S; THITIARCHAKUL S
      MARKED ENHANCEMENT BY RIFAMPICIN AND LACK OF EFFECT OF ISONIAZID ON THE ELIMINATION OF QUININE IN MAN

      British journal of clinical pharmacology
    59. LEE C
      URINARY 6-BETA-HYDROXYCORTISOL IN HUMANS - ANALYSIS, BIOLOGICAL VARIATIONS, AND REFERENCE RANGES

      Clinical biochemistry
    60. INOUE S; INOKUMA M; HARADA T; SHIBUTANI Y; YOSHITAKE T; CHARLES B; ISHIDA J; YAMAGUCHI M
      SIMULTANEOUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF6-BETA-HYDROXYCORTISOL AND CORTISOL IN URINE WITH FLUORESCENCE DETECTION AND ITS APPLICATION FOR ESTIMATING HEPATIC DRUG-METABOLIZING ENZYME-INDUCTION

      Journal of chromatography B. Biomedical applications
    61. FUCHS W; SENNEWALD R; KLOTZ U
      LANSOPRAZOLE DOES NOT AFFECT THE BIOAVAILABILITY OF ORAL-CONTRACEPTIVES

      British journal of clinical pharmacology
    62. PIRMOHAMED M; ALLOTT R; GREEN VJ; KITTERINGHAM NR; CHADWICK D; PARK BK
      LYMPHOCYTE MICROSOMAL EPOXIDE HYDROLASE IN PATIENTS ON CARBAMAZEPINE THERAPY

      British journal of clinical pharmacology
    63. ROST KL; BROSICKE H; HEINEMEYER G; ROOTS I
      SPECIFIC AND DOSE-DEPENDENT ENZYME-INDUCTION BY OMEPRAZOLE IN HUMAN-BEINGS

      Hepatology
    64. ROST KL; BROSICKE H; HEINEMEYER G; ROOTS I
      SPECIFIC AND DOSE-DEPENDENT ENZYME-INDUCTION BY OMEPRAZOLE IN HUMAN-BEINGS

      Hepatology
    65. LEDINH T; CHRISTOFOROV B
      HEPATIC DRUGS METABOLISM STUDY - TOWARDS A RATIONALIZATION OF NEW DRUG DEVELOPMENT

      Therapie
    66. THUMMEL KE; SHEN DD; PODOLL TD; KUNZE KL; TRAGER WF; HARTWELL PS; RAISYS VA; MARSH CL; MCVICAR JP; BARR DM; PERKINS JD; CARITHERS RL
      USE OF MIDAZOLAM AS A HUMAN CYTOCHROME-P450 3A PROBE .1. IN-VITRO IN-VIVO CORRELATION IN LIVER-TRANSPLANT PATIENTS

      The Journal of pharmacology and experimental therapeutics
    67. PINQUIER JL; JOSEPH X; DELAFORGE M; LEJUS C; BOUCHER JL; DELAUTURE D; KAHAN A; STRAUCH G
      LACK OF EFFECT OF PHENOBARBITAL ON EX-VIVO LEUKOCYTE OXIDATIVE-METABOLISM IN HEALTHY-VOLUNTEERS

      Fundamental and clinical pharmacology
    68. SCHRENZEL J; DAYER P; LEEMANN T; WEIDEKAMM E; PORTMANN R; LEW DP
      INFLUENCE OF RIFAMPIN ON FLEROXACIN PHARMACOKINETICS

      Antimicrobial agents and chemotherapy
    69. SANDSTAD O; OSNES T; SKAR V; OSNES M
      URINARY D-GLUCARIC ACID, A MARKER SUBSTANCE FOR MICROSOMAL-ENZYME INDUCTION - METHODOLOGICAL ASPECTS, RESPONSES TO ALCOHOL AND FINDINGS IN WORKERS EXPOSED TO TOLUENE

      Scandinavian journal of clinical & laboratory investigation
    70. KINIRONS MT; OSHEA D; DOWNING TE; FITZWILLIAM AT; JOELLENBECK L; GROOPMAN JD; WILKINSON GR; WOOD AJJ
      ABSENCE OF CORRELATIONS AMONG 3 PUTATIVE IN-VIVO PROBES OF HUMAN CYTOCHROME-P4503A ACTIVITY IN YOUNG HEALTHY-MEN

      Clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 15:15:47